<DOC>
	<DOCNO>NCT01096615</DOCNO>
	<brief_summary>The aim study show improvement quality life 5th week product consumption ( probiotic Lactobacillus paracasei LP-33 ) ( assess RQLQ global score ) subject persistent allergic rhinitis currently treat Loratadine oral anti-histaminic treatment .</brief_summary>
	<brief_title>Effect Of Probiotic Lactobacillus Paracasei Lp-33 For The Management Of Rhinitis In People Sensitized To Allergens</brief_title>
	<detailed_description>Oral H1-antihistamines first treatment recommend allergic rhinitis ( Bousquet et al , 2008 ) however completely alleviate symptom . This new study therefore assess effect Lactobacillus paracasei LP-33 management nasal ocular symptom , addition H1-antihistamines treatment . The main objective evaluate effect Lactobacillus paracasei LP-33 quality life . Additionally allergic rhinitis symptom ( nasal eye symptom ) immunological parameter evaluate , supplementation . Lactobacillus paracasei LP-33 target general population improve quality life people sensitize allergen . The study conduct Europe adult subject persistent allergic rhinitis .</detailed_description>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>Male female subject ; Aged 18 60 year ; People nasal ocular discomfort least sensitized grass pollen ; Subject PER allergy ( persistent form ) define ARIA guideline recurrent history seasonal allergic rhinitis document treatment intake medical dossier . Previous positive skin prick test presence specific serum IgE antibodies class II timothy grass last 5 year . If data available , test detection timothy grass specific serum IgE antibody ( Phadia CAP System ) perform preinclusion visit ; With RQLQ score ≥ 2 ; Subjects agree stop consumption probiotic ( food dietary supplement contain probiotic ) vitamins and/or mineral study ( D10/D7 D49 ) . Female subject efficient contraception asthmatic subject ( control disease without oral corticosteroid ) include study . The baseline period prior treatment Lactobacillus paracasei LP33 7 day . On recommendation consult expert , Pr Bousquet Pr Hamelmann , washout period 3 additional day recommend baseline subject use intranasal corticosteroid inclusion . As consequence , baseline may extend 10 day subject In case subject consume antiH1 ( Loratadine ) ( ) inclusion , ( ) switch Loratadine include . Taking part another clinical trial exclusion period previous clinical trial ; Presenting psychological incapability bad comprehension language ( French German accord concerned country ) understand information letter sign inform consent ; Refusing sign inform consent ; Adult legal protection ( guardianship , wardship ) deprive right follow administrative judicial decision ; Pregnant breastfeed woman ; Use medication could interfere study investigator 's opinion ( antibiotic , etc… ) ; Subject agree stop his/her consumption dietary supplement food contain probiotic his/her supplementation vitamins/minerals study ( D10/D7 D49 ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Allergic rhinitis-Probiotic Lactobacillus paracasei LP-33-</keyword>
</DOC>